4.5 Article

SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease

期刊

CLINICAL BIOCHEMISTRY
卷 43, 期 1-2, 页码 168-177

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.clinbiochem.2009.10.006

关键词

CF; Asthma; COPD; Proteomics; SELDI-TOF-MS; Biomarkers signatures

资金

  1. FCT/FEDER [POCTI/MGI/40878/2001, POCI/SAU-MMO/56163/2004]
  2. FCT/Poly-Annual Funding Program
  3. FEDER/Saude-XXI-Program (Portugal)
  4. FCT-PhD fellowship [SFRH/BD/17744/2004]
  5. Medical Research Council [G9900991B] Funding Source: researchfish

向作者/读者索取更多资源

Objectives: The aim of this work was to establish protein profiles in serum and nasal epithelial cells of cystic fibrosis individuals in comparison with controls, asthma and chronic obstructive pulmonary disease patients for specific biomarker signatures identification. Design and methods: Protein extracts were analyzed by Surface Enhanced Laser Desorption/Ionization Time-Of-Flight Mass-Spectrometry (SELDI-TOF-MS). Results: The mass spectra revealed a set of peaks with differential expression in serum and nasal cells among the different groups studied, resulting into peak signatures representative/specific of each pathology. Logistic regressions were applied to those peaks; sensitivity, specificity, Youden's indexes and area under the curve (AUC) of the respective receiver operating characteristic (ROC) curves were compared. Discussion: Multivariate analysis demonstrated that combination of peaks has a better predictive value than the individual ones. These protein signatures may serve as diagnostic/prognostic markers for the studied diseases with common clinical features, or as follow-up assessment markers of therapeutic interventions. (c) 2009 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All fights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据